Business● Low1h ago · Nov 3, 2026, 10:31 PM
Contineum Therapeutics GAAP EPS of -$0.49
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Contineum Therapeutics has reported its Generally Accepted Accounting Principles (GAAP) Earnings Per Share (EPS) as -$0.49. This provides a financial snapshot of the company's performance.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business13m agoDrone Boat Maker Saildrone Wins Protest Over Navy ContractNYT USBusiness16m agoAmgen boosts 2026 guidance following Q3 beatsSeeking Alpha TechBusiness28m agoLP anticipates Q4 Siding revenue of $390M-$400M as it expands SmartSide distribution networkSeeking Alpha TechBusiness33m agoWhy confidence in the stabilization plan is falling: market noise, the lesson from Peru, and the effect from the US that the Government awaitsClarín